Development and validation of a novel risk score for the detection of insignificant prostate cancer in unscreened patient cohorts

BACKGROUND: Active surveillance is recommended for insignificant prostate cancer (PCa). Tools exist to identify suitable candidates using clinical variables. We aimed to develop and validate a novel risk score (NRS) predicting which patients are harbouring insignificant PCa. METHODS: We used prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutto, Lorenzo, Ahmad, Amar, Urbanova, Katerina, Wagner, Christian, Schuette, Andreas, Addali, Mustafa, Kelly, John D., Sridhar, Ashwin, Nathan, Senthil, Briggs, Timothy P., Witt, Joern H., Shaw, Gregory L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288120/
https://www.ncbi.nlm.nih.gov/pubmed/30478408
http://dx.doi.org/10.1038/s41416-018-0316-2

Ejemplares similares

Ejemplares similares